Caprelsa


Indications and Reactions:

Role Indications Reactions
Primary
Thyroid Cancer 62.2%
Medullary Thyroid Cancer 12.0%
Pain 3.9%
Thyroid Disorder 3.4%
Hypothyroidism 2.6%
Metastases To Liver 2.6%
Atrial Fibrillation 1.7%
Blood Pressure Abnormal 1.3%
Diarrhoea 1.3%
Metastases To Lung 1.3%
Thyroid Cancer Metastatic 1.3%
Anticoagulant Therapy 0.9%
Blood Cholesterol Increased 0.9%
Blood Thyroid Stimulating Hormone Abnormal 0.9%
Depression 0.9%
Diabetes Mellitus 0.9%
Hypertension 0.9%
Benign Prostatic Hyperplasia 0.4%
Blood Calcium 0.4%
Blood Calcium Decreased 0.4%
Rash 22.9%
Electrocardiogram Qt Prolonged 14.6%
Diarrhoea 6.3%
Blood Pressure Increased 5.2%
Fatigue 5.2%
Nausea 5.2%
Death 4.2%
Disease Progression 4.2%
Dyspnoea 4.2%
Headache 4.2%
Acne 3.1%
Metastases To Liver 3.1%
Weight Decreased 3.1%
Arthralgia 2.1%
Cardiac Failure Congestive 2.1%
Cough 2.1%
Electrocardiogram Qt Interval Abnormal 2.1%
Gastrointestinal Haemorrhage 2.1%
Gastrointestinal Perforation 2.1%
Hepatic Enzyme Increased 2.1%
Secondary
Thyroid Cancer 35.2%
Medullary Thyroid Cancer 20.2%
Metastases To Liver 13.6%
Metastases To Lung 6.6%
Pain 3.3%
Blood Thyroid Stimulating Hormone Abnormal 2.8%
Blood Pressure Abnormal 2.3%
Thyroid Disorder 2.3%
Metastases To Bone 1.9%
Metastases To Lymph Nodes 1.9%
Hypothyroidism 1.4%
Psoriasis 1.4%
Weight Increased 1.4%
Benign Prostatic Hyperplasia 0.9%
Coronary Artery Disease 0.9%
Diarrhoea 0.9%
Multiple Myeloma 0.9%
Thyroid Cancer Stage Iv 0.9%
Blood Cholesterol Increased 0.5%
Blood Triglycerides Increased 0.5%
Rash 15.2%
Electrocardiogram Qt Prolonged 9.1%
Acne 7.6%
Photosensitivity Reaction 7.6%
Visual Acuity Reduced 7.6%
Fatigue 6.1%
Venous Occlusion 6.1%
Headache 4.5%
Hypertension 4.5%
Erythema 3.0%
Hepatic Enzyme Increased 3.0%
Hypertensive Crisis 3.0%
Migraine 3.0%
Nausea 3.0%
Rash Generalised 3.0%
Rash Vesicular 3.0%
Throat Irritation 3.0%
Ventricular Extrasystoles 3.0%
Weight Decreased 3.0%
Back Pain 1.5%

Drug Data